Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 65,897 | 154,949 | 70,519 | 222,170 | 221,348 |
| Marketable Securities | 100,138 | 50,130 | 119,966 | N/A | 37,732 |
| Receivables | N/A | N/A | N/A | 886 | 449 |
| TOTAL | $175,870 | $208,754 | $193,741 | $225,274 | $260,992 |
| Non-Current Assets | |||||
| PPE Net | 24,884 | 3,586 | 3,024 | 4,169 | 3,187 |
| Intangibles | 0 | 0 | 5,000 | 5,000 | 0 |
| Other Non-Current Assets | 21,973 | 1,155 | 140 | 140 | 140 |
| TOTAL | $46,857 | $4,741 | $8,164 | $9,309 | $3,327 |
| Total Assets | $222,727 | $213,495 | $201,905 | $234,583 | $264,319 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,103 | 1,707 | 1,731 | 1,474 | 605 |
| Accrued Expenses | 11,271 | 8,784 | 6,964 | 6,476 | 4,007 |
| Other current liabilities | N/A | N/A | N/A | N/A | 1,013 |
| TOTAL | $19,408 | $10,719 | $10,674 | $9,896 | $6,574 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 228 | 1,979 | 1,946 | 949 |
| Other Non-Current Liabilities | 28,362 | 243 | 481 | 386 | 0 |
| TOTAL | $28,362 | $1,609 | $7,203 | $9,087 | $5,153 |
| Total Liabilities | $47,770 | $12,328 | $17,877 | $18,983 | $11,727 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,968 | 6,320 | 6,217 | 4,206 | 2,686 |
| Common Shares | 7 | 6 | N/A | 4 | 3 |
| Retained earnings | -385,029 | -320,543 | -254,062 | -197,915 | -84,168 |
| Other shareholders' equity | -725 | -799 | -958 | -7 | -11 |
| TOTAL | $174,957 | $201,167 | $184,028 | $215,600 | $252,592 |
| Total Liabilities And Equity | $222,727 | $213,495 | $201,905 | $234,583 | $264,319 |